Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/06/2008 | US20080274978 Tryptophan rich mimics; antiinflammatory agents; drug screening for formyl peptide receptor like 1 (FPRL1) activity; arthritis, autoimmune disorders, Alzheimer's disease |
11/06/2008 | US20080274975 Human A beta binding alcohol dehydrogenase (ABAD) inhibitors; amino acid sequence 94-114 of ABAD; Alzheimer's disease; reducing free radical generation, DNA fragmentation and cytochrome C cellular release; preserving cell viability |
11/06/2008 | US20080274971 Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle Differentiation |
11/06/2008 | US20080274970 Vascular adhesion molecules and modulation of their function |
11/06/2008 | US20080274969 Albumin-Fused Kunitz Domain Peptides |
11/06/2008 | US20080274967 Variants of Pigment Epithelium Derived Factor and Uses Thereof |
11/06/2008 | US20080274963 Modulation of Granulosa Cell Apoptosis |
11/06/2008 | US20080274962 Voltage Dependent Anion Channel (Vdac1) Compositions and Methods of Use Thereof for Regulating Apoptosis |
11/06/2008 | US20080274958 Glycosylation of peptides via o-linked glycosylation sequences |
11/06/2008 | US20080274957 Rgd-enriched gelatine-like proteins with enhanced cell binding |
11/06/2008 | US20080274954 Novel protein; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection; determinating esophagual cancer |
11/06/2008 | US20080274950 Intensify binding between cadherin molecules by reducing intramolecular binding within the cadherin molecules; reduce ionic bonding |
11/06/2008 | US20080274914 Screening Method for Somatic Cell Nuclear Reprogramming Substance |
11/06/2008 | US20080274886 Polypeptides can cleave beta -D-xylan polymers at internal (1-4) bonds between adjacent xylopyranosyl units; degrading xylan in cellulos; to treat cellulose in the preparation of edible foodstuffs and animal feed |
11/06/2008 | US20080274548 Using Orphan nuclear receptor and Pentraxin-related gene overexpression as cellular differentiation tool in generation of nervous system tissues; tissue engineering and repair; regenerative medicine |
11/06/2008 | US20080274547 Use of nitric oxide modulators in agrobacterium-mediated plant transformation |
11/06/2008 | US20080274546 Artificial physiological salt solution and manufacturing method for same |
11/06/2008 | US20080274545 Bioreactor Chamber Apparatus, and Method and System for Fabricating and Mechanically Stimulating Natural and Engineered Tissues |
11/06/2008 | US20080274543 Using simulated microgravity environment as tool to enhance proliferation and differentiation of nervous system tissues; tissue engineering and repair; regenerative medicine |
11/06/2008 | US20080274539 Bioreactor for Studying the Effects of Imposed Stimuli on Cellular Activity |
11/06/2008 | US20080274535 Hepatocyte Bioreactor System For Long Term Culture of Functional Hepatocyte Spheroids |
11/06/2008 | US20080274528 Transgenic plant with enhanced carbohydrate production for use in producing bioethanol; environmentally friendly fuels |
11/06/2008 | US20080274506 Host cell comprising vector expressing protein fusion comprising neonatal Fc receptor for use in enhancing antibody-dependent cell-mediated cytotoxicity (ADCC) targeting of cancer cells |
11/06/2008 | US20080274505 Polynucleotide encoding a novel TRP channel family member, LTRPC3, and splice variants thereof |
11/06/2008 | US20080274502 Bacillus Thuringiensis CryET33 and CryET34 Compositions and Uses Therefor |
11/06/2008 | US20080274498 Transgenic methylotrophic yeast for use as bioreactors in production of heterologous polypeptides |
11/06/2008 | US20080274497 Expressing heterologous polypeptide in eukaryotic tissue; tissue engineering; producing vaccines to aid in protection against viral diseases |
11/06/2008 | US20080274496 Methods, Reagents and Instrumentation for Preparing Impregnated Tissue Samples Suitable for Histopathological and Molecular Studies |
11/06/2008 | US20080274491 Using overexpression of integrin-linked kinase (ILK) signaling pathway proteins to differentiate cardiospheres into heart tissue; regenerative medicine; tissue engineering and repair |
11/06/2008 | US20080274477 Forms of Factor Xiia |
11/06/2008 | US20080274475 Hla-e binding |
11/06/2008 | US20080274472 Novel kinases and uses thereof |
11/06/2008 | US20080274470 Using kallikrein-related peptidase 4 (KLK4) gene expression as diagnostic/predicitive too in detection of cell proliferative disorders of urogenital system |
11/06/2008 | US20080274468 Novel means for the diagnosis and therapy of ctcl |
11/06/2008 | US20080274446 Nutrient broth for storage post-mitotic nervous system tissues which express beta tubulin; regenerative medicine; tissue engineering and repair |
11/06/2008 | US20080274259 Delta-5 desaturases and their use in making polyunsaturated fatty acids |
11/06/2008 | US20080274186 NELL-1 enhanced bone mineralization |
11/06/2008 | US20080274185 Inducing angiogenesis enhancing implant success of adult mesenchymal cell scaffolds |
11/06/2008 | US20080274155 Chimeric Cannulae Proteins, Nucleic Acids Encoding Them And Methods For Making And Using Them |
11/06/2008 | US20080274144 Genetically engineered or synthetically produced HCV (hepatitis C virus) E1 envelope proteins or parts thereof comprising disulfides between specific cysteine residues; viral-like particles; biodrugs |
11/06/2008 | US20080274141 Animal cells and processes for the replication of influenza viruses |
11/06/2008 | US20080274133 Soluble Bifunctional Proteins |
11/06/2008 | US20080274125 Human Stem Cell Lines Derived From Es Cells and Uses for Production of Vaccines and Recombinant Proteins |
11/06/2008 | US20080274123 Synaptic vesicle glycoprotein specific immunoglobulin for use in treatment and prevention of liver disorders; tissue targeted therapy |
11/06/2008 | US20080274120 Antiproliferative agents; kits; antibodies against VEGF, an antibody against CD20, rituximab, bortezomib, thalidomide, dexamethasone, vincristine, doxorubicin, and melphalan |
11/06/2008 | US20080274119 Use of Opioid Antagonists to Attenuate Endothelial Cell Proliferation and Migration |
11/06/2008 | US20080274117 Using monoclonal antibody specific to testis-specific serine kinase (TSSK) as tool in controlling reproduction |
11/06/2008 | US20080274112 Axonal growth receptor for use in designing immunoglobulins for prevention and treatment of nervous system, cardiovascular, vision and/or spinal cord injury |
11/06/2008 | US20080274110 Minibodies for use in treatment and prevention of cell proliferative and/or autoimmune disorders |
11/06/2008 | US20080274105 Polypeptide variants with altered effector function |
11/06/2008 | US20080274103 Adenylyl Cyclase Antibodies, Compositions and Uses Thereof |
11/06/2008 | US20080274102 Antibodies to Nik, Their Preparation and Use |
11/06/2008 | US20080274099 Oncofoetal domain specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
11/06/2008 | US20080274092 Erythrocytes Containing Arginine Deiminase |
11/06/2008 | US20080274090 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
11/06/2008 | US20080274089 Inflammation |
11/06/2008 | US20080274088 Mapc Generation of Lung Tissue |
11/06/2008 | US20080274087 Cultured pluripotent animal cell which express CD13 and CD90 for use in treatment and prevention of ischemic injury; regenerative medicine, tissue engineering and repair |
11/06/2008 | US20080274086 Use of Cxcr4 Protein Expression on the Surface of Stem Cells as a Marker for Tumor Tropic Potential |
11/06/2008 | US20080274059 Mite fusion proteins |
11/06/2008 | US20080274055 retain binding affinity for carcinoembryonic antigen; immunogenicity, compared to a parent antibody; vectors; host cells |
11/06/2008 | US20080274049 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
11/06/2008 | US20080274045 Imaging, diagnosis and treatment of disease |
11/06/2008 | US20080273660 Compositions and Methods for Modulating DNA Repair |
11/06/2008 | DE102007020671A1 Growth of inorganic, organic, bioorganic or biological object e.g. tissue or embryos from saturated/supersaturated nutrient solution, comprises flowing growth object in flow direction of the solution and then regulating the flow direction |
11/06/2008 | DE10138876B4 Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung Genetically modified cyclic-nucleotide-gated ion channels, and their use |
11/06/2008 | CA2685409A1 High efficiency electroporation buffer |
11/06/2008 | CA2685400A1 Production of high mannose proteins in plant culture |
11/06/2008 | CA2685295A1 Hemipteran- and coleopteran- active toxin proteins from bacillus thuringiensis |
11/06/2008 | CA2685148A1 New stem cell lines, their application and culture methods |
11/06/2008 | CA2682889A1 Antibodies that bind both il-17a and il-17f and methods of using the same |
11/06/2008 | CA2676808A1 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf) |
11/06/2008 | CA2667196A1 Random homozygous gene perturbation to enhance antibody production |
11/05/2008 | EP1988166A1 Human Toll-like receptor proteins, related reagents and methods |
11/05/2008 | EP1988165A1 Isolated DNA encoding cullin regulator ROC1, isolated proteins encoded by the same, and methods utilizing the same |
11/05/2008 | EP1988162A1 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
11/05/2008 | EP1988160A1 Process fore producing retinal neurocyte from neutral stem cell derived from iris tissue and retinal neurocyte produced by the process |
11/05/2008 | EP1988159A1 Additive for culture medium for use in serum-free culture of animal cell, kit, and use of the additive or kit |
11/05/2008 | EP1988158A1 Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF) |
11/05/2008 | EP1988157A1 Vitreous cell line |
11/05/2008 | EP1988156A1 Cell construct, its process of manufacture, as well as a device, implant and processes for the mechanical stimulation of cells in vitro and in vivo |
11/05/2008 | EP1988152A1 Cell culture construct, cell culture container, construct having spheroid, container having spheroid and method of producing the same |
11/05/2008 | EP1988102A1 Growth factor homolog ZVEGF3 |
11/05/2008 | EP1988099A2 Bacillus thuringiensis insecticidal proteins |
11/05/2008 | EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
11/05/2008 | EP1988094A1 Hapten compound and antibody |
11/05/2008 | EP1987845A2 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor. |
11/05/2008 | EP1987842A1 Cell proliferation inhibitor |
11/05/2008 | EP1987148A1 De-differentiation of astrocytes into neural stem cell using bmi-1 |
11/05/2008 | EP1987146A1 A method for generating reference controls for pharmacogenomic testing |
11/05/2008 | EP1987144A1 DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh |
11/05/2008 | EP1987137A1 Synthesis of sialic acid in plants |
11/05/2008 | EP1987136A2 Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor |
11/05/2008 | EP1987135A2 Methods and compositions relating to stem cell transplantation |
11/05/2008 | EP1987134A2 Scaffolds for organ reconstruction and augmentation |
11/05/2008 | EP1987133A2 Conjunctival tissue system |
11/05/2008 | EP1986712A2 Use of fucans for the purposes of bone grafting, engineering and regeneration |
11/05/2008 | EP1986676A2 Compositions and methods for use of pigment epithelial derived factor (pedf) peptide fragments |
11/05/2008 | EP1986609A2 Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same |
11/05/2008 | EP1896578A4 Piggybac as a tool for genetic manipulation and analysis in vertebrates |